Sensyne Health plc, a clinical artificial intelligence start-up, has signed an exclusive license with diagnostic testing company Excalibur Healthcare Services to use Sensyne’s MagnifEye AI-based reading system in conjunction with Excalibur’s rapid lateral flow test kits.
The license, announced on 9 February, applies to COVID-19 indications and other areas,